- $67.90m
- -$49.31m
- $0.80m
U.S. STOCKS ON THE MOVE-Allogene Therapeutics, Adobe, Williams-Sonoma
Brief: ImageneBio Inc - On Oct 23, Elects Not To Renew Agreement With Miragene - SEC Filing
ImageneBio Inc expected to post a loss of $1.56 a share - Earnings Preview
Brief: Ikena Oncology Announces Stockholder Approval Of Merger With Inmagene Biopharmaceuticals
Brief: Inmagene Successfully Doses First Patient In Adaptive Trial Of IMG-007
Ikena Oncology Inc reports results for the quarter ended March 31 - Earnings Summary
Ikena Oncology Inc expected to post a loss of 19 cents a share - Earnings Preview
Ikena Oncology Inc reports results for the quarter ended December 31 - Earnings Summary
Ikena Oncology Inc expected to post a loss of 19 cents a share - Earnings Preview
Ikena Oncology Inc reports results for the quarter ended in September 30 - Earnings Summary
Ikena Oncology Inc expected to post a loss of 27 cents a share - Earnings Preview
Ikena Oncology Inc reports results for the quarter ended in June - Earnings Summary
Ikena Oncology Inc expected to post a loss of 35 cents a share - Earnings Preview
U.S. RESEARCH ROUNDUP-Autodesk, McKesson, Microstrategy
Ikena Oncology jumps as co to evaluate strategic alternatives
Brief: Ikena Oncology Announces Strategic Update
Brief: Ikena Oncology Says Restructuring Plan Will Result In Termination Of About 18 Employees
Ikena Oncology Inc reports results for the quarter ended in March - Earnings Summary
Ikena Oncology Inc expected to post a loss of 41 cents a share - Earnings Preview